P. P. Bapsy

3.5k total citations · 1 hit paper
21 papers, 915 citations indexed

About

P. P. Bapsy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, P. P. Bapsy has authored 21 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in P. P. Bapsy's work include Cancer Treatment and Pharmacology (8 papers), Sarcoma Diagnosis and Treatment (5 papers) and HER2/EGFR in Cancer Research (4 papers). P. P. Bapsy is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Sarcoma Diagnosis and Treatment (5 papers) and HER2/EGFR in Cancer Research (4 papers). P. P. Bapsy collaborates with scholars based in India, United Kingdom and United States. P. P. Bapsy's co-authors include Ashok K. Vaid, A. Feyereislova, Alison Jones, Michaela Lehle, Sergei Tjulandin, Michael Clemens, Bella Kaufman, John R. Mackey, Michaela K. Jahn and Cédric Révil and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Lung Cancer.

In The Last Decade

P. P. Bapsy

20 papers receiving 890 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

2009 596 citations Bella Kaufman, John R. Mackey et al. Journal of Clinical Oncology profile →

Peers

P. P. Bapsy

ONCOL

PRM

RNMI

Yvonne M.H. Versleijen‐Jonkers Netherlands

Patrick Muraca United States

Frank Priou France

Marius Lund‐Iversen Norway

Barbara Vischioni Italy

Christina Gollan Germany

Jia‐Huei Tsai Taiwan

Volkert B. Wreesmann United States

Adel K. El-Naggar United States

Andrea Sendelhofert Germany

Yvonne M.H. Versleijen‐Jonkers Netherlands

P. P. Bapsy

624 ×1.0

ONCOL

637 ×1.7

PRM

151 ×0.8

95 ×0.5

RNMI

351 ×2.6

Citations per year, relative to P. P. Bapsy P. P. Bapsy (= 1×) peers Yvonne M.H. Versleijen‐Jonkers

Countries citing papers authored by P. P. Bapsy

Since Specialization

Citations

This map shows the geographic impact of P. P. Bapsy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. P. Bapsy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. P. Bapsy more than expected).

Fields of papers citing papers by P. P. Bapsy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. P. Bapsy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. P. Bapsy. The network helps show where P. P. Bapsy may publish in the future.

Co-authorship network of co-authors of P. P. Bapsy

This figure shows the co-authorship network connecting the top 25 collaborators of P. P. Bapsy. A scholar is included among the top collaborators of P. P. Bapsy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. P. Bapsy. P. P. Bapsy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kohli, Sakshi, et al.. (2017). Immune modulation by dendritic-cell-based cancer vaccines. Journal of Biosciences. 42(1). 161–173. 15 indexed citations

Kohli, Sakshi, et al.. (2017). A Retrospective Analysis Comparing APCEDEN ^® Dendritic Cell Immunotherapy with Best Supportive Care in Refractory Cancer. Immunotherapy. 9(11). 889–897. 16 indexed citations

Bapsy, P. P., et al.. (2014). Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care. Cytotherapy. 16(2). 234–244. 37 indexed citations

Digumarti, Raghunadharao, P. P. Bapsy, G.S. Bhattacharyya, et al.. (2014). Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 86(2). 231–236. 34 indexed citations

Jain, Minish, Shekhar Patil, Anand Pathak, et al.. (2014). The efficacy and safety of paclitaxel injection concentrate for nano-dispersion (PICN) at two different doses versus paclitaxel albumin-stabilized nanoparticle formulation in subjects with metastatic breast cancer (MBC).. Journal of Clinical Oncology. 32(15_suppl). 1069–1069. 3 indexed citations

Ranade, Anantbhushan, P. P. Bapsy, Shona Nag, et al.. (2012). A multicenter phase II randomized study of Cremophor‐free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline. Asia-Pacific Journal of Clinical Oncology. 9(2). 176–181. 15 indexed citations

Bapsy, P. P.. (2012). Ovarian cancer.. PubMed. 110(12). 894–7. 2 indexed citations

Kaufman, Bella, John R. Mackey, Michael Clemens, et al.. (2009). Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study. Journal of Clinical Oncology. 27(33). 5529–5537. 596 indexed citations breakdown →

Ramaswamy, Girija, et al.. (2008). Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma. Indian Journal of Clinical Biochemistry. 23(4). 345–351. 8 indexed citations

10.

Stadtmauer, Edward A., David S. Siegel, Dan T. Vogl, et al.. (2008). A Phase 1 Trial of Fluphenazine HCl (Fz), a Serotonin Antagonist, in Relapsed and Refractory Multiple Myeloma. Blood. 112(11). 5188–5188. 2 indexed citations

11.

Ranade, Anantbhushan, P. P. Bapsy, Raghunadharao Digumarti, et al.. (2008). A novel, cremophor-free, polymeric nanoparticle paclitaxel (do/ndr/02) multicenter study in advanced/ metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1115–1115. 5 indexed citations

12.

Bapsy, P. P., et al.. (2007). A case of primary rhabdomyosarcoma of the breast. Indian Journal of Surgery. 69(5). 201–202. 5 indexed citations

13.

Bapsy, P. P., et al.. (2005). Retroperitoneal inflammatory myofibroblastic tumor. World Journal of Surgical Oncology. 3(1). 66–66. 33 indexed citations

14.

Mukhopadhyay, A., Kushal Patel, Mammen Chandy, et al.. (2005). Analysis of safety profile of thalidomide in multiple myeloma: A multicenter Indian experience. Journal of Clinical Oncology. 23(16_suppl). 6709–6709.

15.

Bapsy, P. P., et al.. (2004). DO/NDR/02 a novel polymeric nanoparticle paclitaxel: Results of a phase I dose escalation study. Journal of Clinical Oncology. 22(14_suppl). 2026–2026. 5 indexed citations

16.

Pavithran, K, et al.. (1997). Pediatric Solitary Plasmacytoma. Acta Oncologica. 36(1). 83–84. 13 indexed citations

17.

Doval, D.C., et al.. (1997). Osteosarcoma of the jaw bones. British Journal of Oral and Maxillofacial Surgery. 35(5). 357–362. 57 indexed citations

18.

Pavithran, K, et al.. (1997). Rhabdomyosarcoma of the Oral Cavity:Report of Eight Cases. Acta Oncologica. 36(8). 819–821. 14 indexed citations

19.

Doval, D.C., et al.. (1997). Synovial sarcoma of the neck. European Archives of Oto-Rhino-Laryngology. 254(5). 246–250. 32 indexed citations

20.

Doval, Dinesh Chandra, et al.. (1994). Rhabdomyosarcoma of the tongue. British Journal of Oral and Maxillofacial Surgery. 32(3). 183–186. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact